Semaglutide
HealthWeight-loss drug Semaglutide could significantly reduce the risk of heart attacks
A new study shows that semaglutide, an anti-obesity drug, significantly reduces the risk of heart attacks and strokes in overweight people with cardiovascular disease, even those with heart failure.
Joshua Shavit
